Home

I am the Co-founder and CEO of a drug discovery platform startup (in stealth) based in the San Francisco Bay Area. As an entrepreneurial biotech leader, I excel at building high-performing teams and bring a unique fluency spanning biological, computational, and mathematical sciences to drug discovery challenges.

Previously, I was a founding member of Atomic AI, where we accelerated the discovery of RNA-targeting and RNA-based medicines by integrating machine learning with high-throughput experiments. I led the bioscience platform efforts, established our initial drug discovery efforts, and helped grow the company to 25 people.

Trained as a full-stack experimental and computational scientist, my research spans functional genomics, RNA biology, artificial intelligence, data science, and multiplexed screening assay development. I did my Ph.D. at Stanford University in the department of Computer Science and was based in Roger Kornberg's lab in the department of Structural Biology. I was an Accel Innovation Scholar and a NDSEG Fellowship winner.

I wrote a highly cited paper proposing that the two-meter-long human genome folds inside the microscopic cell nucleus through a novel mechanism of loop extrusion, and used molecular dynamics simulations and CRISPR gene editing to engineer genomes in 3D. This prompted subsequent demonstrations (1, 2) that the Cohesin complex served as the unknown molecular motor in our loop extrusion model—a surprising new function that had eluded researchers despite 20 years of intensive study.

I majored in mathematics and minored in computer science at Harvard, and also completed a masters degree at New England Conservatory, where I studied flute performance with Paula Robison.